{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T04:14:35Z","timestamp":1772165675162,"version":"3.50.1"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,2,5]],"date-time":"2025-02-05T00:00:00Z","timestamp":1738713600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,2,5]],"date-time":"2025-02-05T00:00:00Z","timestamp":1738713600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"DOI":"10.1186\/s12879-025-10509-1","type":"journal-article","created":{"date-parts":[[2025,2,5]],"date-time":"2025-02-05T08:05:32Z","timestamp":1738742732000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Difference of clinical characteristics in patients with reinfection and primary infection variants of SARS-CoV-2: a retrospective study in China"],"prefix":"10.1186","volume":"25","author":[{"given":"Chao-Chao","family":"Qiu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiao-Qing","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qiang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ya-Long","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiao-Qiao","family":"Su","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ming-Ying","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Le-Fei","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhi-Ruo","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fang","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shang-Ren","family":"Xie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ji-Chan","family":"Shi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xian-Gao","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,2,5]]},"reference":[{"issue":"11","key":"10509_CR1","doi-asserted-by":"publisher","first-page":"2050","DOI":"10.1101\/2022.01.25.477784","volume":"82","author":"S-M Gobeil","year":"2022","unstructured":"Gobeil S-M, Henderson R, Stalls V, et al. Structural diversity of the SARS-CoV-2 omicron spike. Mol Cell. 2022;82(11):2050\u201368. https:\/\/doi.org\/10.1101\/2022.01.25.477784.","journal-title":"Mol Cell"},{"key":"10509_CR2","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.ijbiomac","volume":"204","author":"RM El-Shabasy","year":"2022","unstructured":"El-Shabasy RM, Nayel MA, Taher MM, Abdelmonem R, Shoueir KR, Kenawy ER, et al. Three waves changes, new variant strains, and vaccination effect against COVID-19 pandemic. Int J Biol Macromol. 2022;204:161\u20138. https:\/\/doi.org\/10.1016\/j.ijbiomac.","journal-title":"Int J Biol Macromol"},{"key":"10509_CR3","doi-asserted-by":"publisher","first-page":"160","DOI":"10.14163\/j.cnki.11-5547\/r.2023.07.044","volume":"07","author":"M Liu","year":"2023","unstructured":"Liu M, Zhang B-Y, Zhao L-H, et al. Pathogenesis and epidemiology of Omicron, a new coronavirus variant[J]. China Practical Med. 2023;07:160\u20133. https:\/\/doi.org\/10.14163\/j.cnki.11-5547\/r.2023.07.044.","journal-title":"China Practical Med"},{"key":"10509_CR4","doi-asserted-by":"publisher","unstructured":"Ikbel HH. Covid-19 vaccines and variants of concern: a review.[J].Reviews in medical virology,2022, 32(4):1099\u2013654. https:\/\/doi.org\/10.1002\/rmv.2313","DOI":"10.1002\/rmv.2313"},{"key":"10509_CR5","doi-asserted-by":"publisher","unstructured":"Lu YJ, Okpani A I,McLeod C, B et al. Masking strategy to protect healthcare workers from COVID-19:An umbrella meta-analysis.[J]. Infection, disease & health,2023,01:2468\u2013\u20090869. https:\/\/doi.org\/10.1016\/J.IDH.2023.01.004","DOI":"10.1016\/J.IDH.2023.01.004"},{"key":"10509_CR6","doi-asserted-by":"publisher","unstructured":"Peng D-P, Xing X-Y,Wang Y, Zhang K-Y,Niu JQ et al. Epidemiologic and clinical characteristics of a novel omicron variant of coronavirus[J]. Chin J Viral Dis 2022,05:385\u20139. https:\/\/doi.org\/10.16505\/j.2095-0136.2022.0058","DOI":"10.16505\/j.2095-0136.2022.0058"},{"issue":"2","key":"10509_CR7","doi-asserted-by":"publisher","first-page":"412422","DOI":"10.1021\/acs.jcim.1c01451","volume":"62","author":"J Chen","year":"2022","unstructured":"Chen J, Wang R, Gilby NB, et al. Omicron variant (B.1.1.529): infectivity, vaccine breakthrough, and antibody resistance[J]. J Chem Inf Model. 2022;62(2):412422. https:\/\/doi.org\/10.1021\/acs.jcim.1c01451.","journal-title":"J Chem Inf Model"},{"key":"10509_CR8","doi-asserted-by":"publisher","unstructured":"Xiaofeng H, Jiao S, Yu\u2019nan M et al. A comprehensive analysis of the efficacy and effectiveness of COVID-19 vaccines.[J].Frontiers in immunology,2022, 13: 1664\u20133224. https:\/\/doi.org\/10.3389\/fimmu.2022.945930","DOI":"10.3389\/fimmu.2022.945930"},{"key":"10509_CR9","unstructured":"Satistics OFN. Coronavirus (COVID-19) Infection Survey, characteristics of people testing positive for COVID-19, UK. 2022 [EB\/OL].(2022) Available at: https:\/\/www.ons.gov.uk\/peoplepopulationandcommunity\/healthandsocialcare\/conditionsanddiseases\/datasets\/coronaviruscovid19infectionsinthecommunityinengland"},{"issue":"3","key":"10509_CR10","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1016\/j.cmi.2020.11.028","volume":"27","author":"D Yahav","year":"2021","unstructured":"Yahav D, Yelin D, Eckerle I, Eberhardt CS, Wang J, Cao B, Kaiser L. Definitions for coronavirus disease 2019 reinfection, relapse and PCR re-positivity. Clin Microbiol Infect. 2021;27(3):315\u20138. Epub 2020 Dec 5.","journal-title":"Clin Microbiol Infect"},{"key":"10509_CR11","unstructured":"World Health Organization. COVID-19 Clinical management: living guidance[EB\/OL].(2023)Available at: https:\/\/www.who.int\/teams\/health-care-readiness\/covid-19"},{"key":"10509_CR12","doi-asserted-by":"publisher","unstructured":"World Health Organization. Update to living WHO guideline on drugs for covid-19.[J]. BMJ (Clinical research ed.),2023,380(57):1756\u20131833. https:\/\/doi.org\/10.1136\/bmj.p57","DOI":"10.1136\/bmj.p57"},{"key":"10509_CR13","doi-asserted-by":"publisher","unstructured":"GarciaBeltran WF, Lam EC, ST DENIS K, et al. Multiple SARS-CoV-2 variants escape neutralization by vaccine-induced humoral immunity[J]. Cell. 2021;184(9):2372\u201383. https:\/\/doi.org\/10.1016\/J.CELL.2021.04.006.","DOI":"10.1016\/J.CELL.2021.04.006"},{"issue":"7871","key":"10509_CR14","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1038\/S41586-021-03777-9","volume":"596","author":"D Planas","year":"2021","unstructured":"Planas D, Veyer D, Baidaliuk A, et al. Reduced sensitivity of SARS-CoV-2 variant Delta to antibody neutralization[J]. Nature. 2021;596(7871):276\u201380. https:\/\/doi.org\/10.1038\/S41586-021-03777-9.","journal-title":"Nature"},{"issue":"13","key":"10509_CR15","doi-asserted-by":"publisher","first-page":"2200247","DOI":"10.2807\/1560-7917.ES.2022.27.13.2200247","volume":"27","author":"J Bastard","year":"2022","unstructured":"Bastard J, Taisne B, Figoni J, Mailles A, Durand J, Fayad M, Josset L, Maisa A, van der Werf S, Parent du Ch\u00e2telet I, Bernard-Stoecklin S. Impact of the Omicron variant on SARS-CoV-2 reinfections in France, March 2021 to February 2022. Euro Surveill. 2022;27(13):2200247. https:\/\/doi.org\/10.2807\/1560-7917.ES.2022.27.13.2200247.","journal-title":"Euro Surveill"},{"issue":"1","key":"10509_CR16","doi-asserted-by":"publisher","first-page":"894","DOI":"10.1080\/22221751.2022.2052358","volume":"11","author":"NN Nguyen","year":"2022","unstructured":"Nguyen NN, Houhamdi L, Hoang VT, Delerce J, Delorme L, Colson P, Brouqui P, Fournier PE, Raoult D, Gautret P, et al. SARS-CoV-2 reinfection and COVID-19 severity. Emerg Microbes Infect. 2022;11(1):894\u2013901. https:\/\/doi.org\/10.1080\/22221751.2022.2052358.","journal-title":"Emerg Microbes Infect"},{"key":"10509_CR17","doi-asserted-by":"publisher","unstructured":"Liew F, Talwar S, Cross A, Willett BJ, Scott S et al. SARS-CoV-2-specific nasal IgA wanes 9 months after hospitalisation with COVID-19 and is not induced by subsequent vaccination[J].EBioMedicine,2023,87(1):2352\u20133964. https:\/\/doi.org\/10.1016\/j.ebiom.2022.104402","DOI":"10.1016\/j.ebiom.2022.104402"},{"issue":"3","key":"10509_CR18","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1016\/j.dsx.2021.05.008","volume":"15","author":"V Kumar","year":"2021","unstructured":"Kumar V, Iyengar K, Garg R, Vaishya R, et al. Elucidating reasons of COVID-19 re-infection and its management strategies. Diabetes Metab Syndr. 2021;15(3):1001\u20136. https:\/\/doi.org\/10.1016\/j.dsx.2021.05.008.","journal-title":"Diabetes Metab Syndr"},{"issue":"6","key":"10509_CR19","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1016\/S1473-3099(22)00069-X","volume":"22","author":"C Cohen","year":"2022","unstructured":"Cohen C, Kleynhans J, von Gottberg A, et al. SARS-CoV-2 incidence, transmission, and reinfection in a rural and an urban setting: results of the PHIRST-C cohort study, South Africa, 2020-21. Lancet Infect Dis. 2022;22(6):821\u201334. https:\/\/doi.org\/10.1016\/S1473-3099(22)00069-X.","journal-title":"Lancet Infect Dis"},{"key":"10509_CR20","doi-asserted-by":"publisher","first-page":"876409","DOI":"10.3389\/fmicb.2022.876409","volume":"13","author":"B Borras-Bermejo","year":"2022","unstructured":"Borras-Bermejo B, Pi\u00f1ana M, Andr\u00e9s C, et al. Characteristics of 24 SARS-CoV-2-Sequenced reinfection cases in a Tertiary Hospital in Spain. Front Microbiol. 2022;13:876409. https:\/\/doi.org\/10.3389\/fmicb.2022.876409.","journal-title":"Front Microbiol"},{"issue":"7","key":"10509_CR21","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1080\/23744235.2021.1910339","volume":"53","author":"West Jack","year":"2021","unstructured":"West Jack. SARS-CoV-2 reinfection-what could the absence of evidence suggest[J]. Infect Dis. 2021;53(7):486\u20137. https:\/\/doi.org\/10.1080\/23744235.2021.1910339.","journal-title":"Infect Dis"},{"issue":"10379","key":"10509_CR22","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1016\/S0140-6736(22)02465-5","volume":"401","author":"COVID-19 Forecasting Team","year":"2023","unstructured":"COVID-19 Forecasting Team. Past SARS-CoV-2 infection protection against re-infection: a systematic review and meta-analysis[J]. Lancet. 2023;401(10379):833\u201342. https:\/\/doi.org\/10.1016\/S0140-6736(22)02465-5.","journal-title":"Lancet"},{"key":"10509_CR23","doi-asserted-by":"publisher","unstructured":"Muhammad A, Atif G, Rabia J et al. Correlation of viral load with the clinical and biochemical profiles of COVID-19 patients.[J]. Cureus,2021, 13(7):2168\u20138184. https:\/\/doi.org\/10.7759\/cureus.16655","DOI":"10.7759\/cureus.16655"},{"key":"10509_CR24","doi-asserted-by":"publisher","unstructured":"EJJ BDA, Roshan T et al. Association of COVID-19 real-time reverse transcription-polymerase chain reaction (RT-PCR) cycle threshold value with surrogate markers of Disease Severity.[J]. Cureus,2022, 14(11): 2168\u20138184. https:\/\/doi.org\/10.7759\/cureus.31034","DOI":"10.7759\/cureus.31034"},{"key":"10509_CR25","doi-asserted-by":"publisher","unstructured":"AR,Raghavendra T, AAS A et al. Viral dynamics and Real-Time RT-PCR ct values correlation with Disease Severity in COVID-19[J]. Diagnostics,2021,11(6):2075\u20134418.https:\/\/doi.org\/10.3390\/diagnostics11061091","DOI":"10.3390\/diagnostics11061091"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-025-10509-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-025-10509-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-025-10509-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,5]],"date-time":"2025-02-05T08:05:39Z","timestamp":1738742739000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-025-10509-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,5]]},"references-count":25,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["10509"],"URL":"https:\/\/doi.org\/10.1186\/s12879-025-10509-1","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-4193207\/v1","asserted-by":"object"}]},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,5]]},"assertion":[{"value":"30 March 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 January 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 February 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Informed consent was obtained from all enrolled patients, who were duly informed and who voluntarily agreed to participate in the study. This study was approved by the Ethics Committee of Wenzhou Central Hospital of Zhejiang Province (approval number: L2023-03-022) in China.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable in this section.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"173"}}